At the same time, in the actual maintenance process, some things need to be paid attention to by the owner:
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.
Enzalutamide Intermediate Cas No 143782-23-4,Enzalutamide Project Cas 143782-23-4,Enzalutamide Cas 915087-24-0,Enzalutamide Cas 609784-45-4
 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com